Originally Posted by Anonymous
and did you happen to look at the calcitonin concentrations for the 4 Victoza patients pre-trial? Also high. Clearly, something going on in all these patients prior to the trial. Even the MTC patient on the comparator.
Quit stirring an empty pot.
There is no mention of calcitonin concentrations in the 4 Victoza patients - this is because they were normal. If you read the complete paragraph it appears that NN tested every participants' calcitonin pre-trial.
3 more people out of approximately 250 developed thyroid cancer than would have if they were kept off Victoza and this was a relatively short study in comparison to the length of time a person would be expected to be on Victoza. Logically it would be expected that additional thyroid tumors would be revealed in a longer study.